Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, Gottingen, Germany.
Bioconjug Chem. 2010 Aug 18;21(8):1465-72. doi: 10.1021/bc100054c.
We describe the preparation, biophysical characterization, and receptor-mediated cellular internalization of biotinylated lipid particles (BLPs) loaded on the surface and internally with two distinct (colors) of quantum dot (QD) probes. BLPs were formulated with 1.4 and 2.7 mol % PEG-lipids containing either a fusogenic or pH-sensitive lipid to promote bilayer destabilization of endosomal membranes and favor QD cytoplasmic release. The amount of PEG was chosen to provide steric stabilization of the final construct. BLPs were loaded with a red-emitting QD(655) and surface coated with a green-emitting QD(525) conjugated to the epidermal growth factor (EGF) ligand in order to target the epidermal growth factor receptor (EGFR). The targeted and QD labeled BLPs showed strong and selective binding to EGFR-expressing tumor cell line and subsequent internalization. The dual-color QD labeling strategy and colocalization analysis allow prolonged live cell imaging of BLPs and loaded cargo independently, using a single excitation wavelength and simultaneous detection of both QDs. The chemistry of bioconjugation for the EGF ligand, the QDs, and the BLPs in a single lipid particle, involves only biotin-streptavidin interaction without requiring further purification from free EGF-QDs preformed complexes. Coupled with an encapsulated drug, the targeted and QD-labeled BLPs could provide imaging and drug delivery in a single multifunctional carrier.
我们描述了生物素化脂质颗粒 (BLPs) 的制备、生物物理特性表征以及受受体介导的细胞内化,这些 BLPs 表面和内部负载有两种不同(颜色)的量子点 (QD) 探针。BLPs 由含有融合或 pH 敏感脂质的 1.4 和 2.7 mol% PEG-脂质组成,以促进内体膜的双层不稳定,并有利于 QD 细胞质释放。PEG 的量选择为最终构建体提供空间稳定。BLPs 负载红色发射 QD(655),表面涂覆绿色发射 QD(525),与表皮生长因子 (EGF) 配体缀合,以靶向表皮生长因子受体 (EGFR)。靶向和 QD 标记的 BLPs 表现出与表达 EGFR 的肿瘤细胞系的强烈和选择性结合,随后发生内化。双量子点标记策略和共定位分析允许使用单个激发波长独立、持续地对 BLPs 和负载货物进行活细胞成像,同时检测两种 QD。EGF 配体、QD 和 BLPs 在单个脂质颗粒中的生物缀合化学仅涉及生物素-链霉亲和素相互作用,而不需要进一步从预先形成的游离 EGF-QD 复合物中纯化。与封装药物结合,靶向和 QD 标记的 BLPs 可以在单个多功能载体中提供成像和药物递送。